• LAST PRICE
    0.6500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.6500
  • Day Range
    ---
  • 52 Week Range
    Low 0.2110
    High 3.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNUNZ
Nunzia Pharmaceutical Corp
282.2M
-3.0x
---
United StatesAVDL
Avadel Pharmaceuticals PLC
288.2M
-2.1x
---
United StatesVECT
VectivBio Holding AG
221.3M
-2.0x
---
United StatesBGXX
Bright Green Corp
211.7M
-13.1x
---
United StatesMRNS
Marinus Pharmaceuticals Inc
262.6M
-2.4x
---
United StatesSMTI
Sanara Medtech Inc
226.8M
-17.4x
---
As of 2022-09-25

Company Information

Nunzia Pharmaceutical Corporation owns the rights to Nunzia, a nutraceutical that treats Autism, Fragile X, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD) and other such disorders. The Company manufactures, markets and plan to distribute Nunzia, direct to consumers through its website, www.nunziapharma.com, and through wholesalers. Nunzia is nutraceutical product is designed to treat the symptoms of these wide-ranging medical conditions. Nunzia product is intended to increase sensory, social, and daily living skills, as well as increasing attention span, memory retention, focus, comprehension and learning while decreasing anxiety, stress, fixations, fidgeting and outside detractions.

Contact Information

Headquarters
3422 W Pico BlvdLOS ANGELES, CA, United States 90019-4531
Phone
714-609-9117
Fax
972-386-7864

Executives

Chairman of the Board, Chief Executive Officer
R. Steve Mills
Chief Financial Officer, Vice President
Kingman Hitz
Chief Operating Officer, Senior Vice President, Treasurer, Secretary, Director
Roger Kron
Director
G.David Henry
Director
Mary Pohlmeier

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$282.2M
Revenue (TTM)
$0.00
Shares Outstanding
434.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-2.94
EPS
$-0.22
Book Value
$0.00
P/E Ratio
-3.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.